Rare diseases
Investigational molecules
Locations
100 Morris Street, 07960-4563, United States
Clinical activity is centered on Type 1 Diabetes Mellitus, with interest in disease-modifying treatment for individuals affected by autoimmune beta-cell destruction and ongoing endocrine dysfunction.
The trial portfolio reflects a focus on maintaining long-term safety in the setting of immunotherapy used for Type 1 Diabetes management.
Provention Bio Inc. runs clinical trials in conditions such as Diabetes mellitus, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
